Search

everythinglearnresearchcommunity

for

Search:↓

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Patients follow treatment well, but many change medicines; good information helps compliance.

Objective assessment is needed to accurately determine medication use and adherence.

Researchers developed a nanomedicine for acne treatment that delivers medication with less irritation and is non-irritating for oily skin.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

An infant with scalp fungus was cured after extended treatment with antifungal medication.

Autoimmune hepatitis in children often affects girls and can be treated successfully with medication.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

The boy's hair loss was caused by the tuberculosis drug isoniazid but grew back after stopping the medication.

The document concludes that managing PCOS requires a comprehensive approach, including lifestyle changes and medication, to improve symptoms and reduce health risks.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Tamsulosin increases the risk of floppy iris during eye surgery.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Optimized film improves finasteride skin absorption and treatment efficiency.

Treating hair loss requires a comprehensive approach that addresses both physical and emotional aspects, with a focus on diagnosis, patient education, and good communication.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

Dissolving microneedles show promise for delivering medication through the skin but face challenges like manufacturing complexity and regulatory hurdles.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.